These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25371662)

  • 1. PPAR Gamma Expression Levels during Development of Heart Failure in Patients with Coronary Artery Disease after Coronary Artery Bypass-Grafting.
    Wojtkowska I; Tysarowski A; Seliga K; Siedlecki JA; Juraszyński Z; Marona M; Greszata L; Skrobisz A; Kaminski K; Sawicki R; Stępińska J
    PPAR Res; 2014; 2014():242790. PubMed ID: 25371662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial Expression of PPAR
    Wojtkowska I; Bonda TA; Wolszakiewicz J; Osak J; Tysarowski A; Seliga K; Siedlecki JA; Winnicka MM; Piotrowicz R; Stępińska J
    PPAR Res; 2017; 2017():1924907. PubMed ID: 29093735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.
    Rothenburger M; Stypmann J; Bruch C; Wichter T; Hoppe M; Drees G; Berendes E; Huelsken G; Loeher A; Welp H; Röttger C; Schmid C; Scheld HH; Tjan TD
    J Heart Lung Transplant; 2006 May; 25(5):596-602. PubMed ID: 16678040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARG2 Pro12Ala and TNF
    Wojtkowska I; Bonda TA; Tysarowski A; Seliga K; Siedlecki JA; Winnicka MM; Stępińska J
    PPAR Res; 2019; 2019():1932036. PubMed ID: 31275366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 5-Year Outcomes After Coronary Artery Bypass Grafting in Heart Failure Patients With Versus Without Preserved Left Ventricular Ejection Fraction (from the CREDO-Kyoto CABG Registry Cohort-2).
    Marui A; Nishiwaki N; Komiya T; Hanyu M; Tanaka S; Kimura T; Sakata R;
    Am J Cardiol; 2015 Aug; 116(4):580-6. PubMed ID: 26092271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of Left Ventricular Function After Percutaneous Coronary Intervention Compared to Coronary Artery Bypass Grafting in Patients with Multi-Vessel Coronary Disease and Left Ventricular Dysfunction.
    Yee NP; Siu AM; Davis J; Kao J
    Hawaii J Med Public Health; 2016 Sep; 75(9):273-7. PubMed ID: 27688953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary artery disease, coronary revascularization, and outcomes in chronic advanced systolic heart failure.
    Gheorghiade M; Flaherty JD; Fonarow GC; Desai RV; Lee R; McGiffin D; Love TE; Aban I; Eichhorn EJ; Bonow RO; Ahmed A
    Int J Cardiol; 2011 Aug; 151(1):69-75. PubMed ID: 20554334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel nomogram to predict perioperative acute kidney injury following isolated coronary artery bypass grafting surgery with impaired left ventricular ejection fraction.
    Lin H; Hou J; Tang H; Chen K; Sun H; Zheng Z; Hu S
    BMC Cardiovasc Disord; 2020 Dec; 20(1):517. PubMed ID: 33302875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High N-Terminal proB-Type Natriuretic Peptide Indicates Elevated Risk of Death after Percutaneous Coronary Intervention Compared to Coronary Artery Bypass Surgery in Patients with Left Ventricular Dysfunction.
    Roth C; Schneider M; Dalos D; Gangl C; Toth C; Goliasch G; Berger R
    J Clin Med; 2019 Jun; 8(6):. PubMed ID: 31234593
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of cardiac multidetector computed tomography in the exclusion of ischemic etiology in heart failure patients.
    Sousa PA; Bettencourt N; Dias Ferreira N; Carvalho M; Leite D; Ferreira W; de Jesus I; Gama V
    Rev Port Cardiol; 2014 Oct; 33(10):629-36. PubMed ID: 25281557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival After Coronary Artery Bypass Grafting in Patients With Preoperative Heart Failure and Preserved vs Reduced Ejection Fraction.
    Dalén M; Lund LH; Ivert T; Holzmann MJ; Sartipy U
    JAMA Cardiol; 2016 Aug; 1(5):530-8. PubMed ID: 27434816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Change of N-terminal pro-brain natriuretic peptide and big endothelin in patients undergoing coronary artery bypass grafting].
    Lu YF; Qi HW; Tang CZ; Wu MY; Wang Y; Zhao FH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Nov; 19(11):667-70. PubMed ID: 17996134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of circulating endothelin-1 as a predictor of coronary artery disease status and clinical outcomes following coronary artery catheterization.
    Mayyas F; Al-Jarrah M; Ibrahim K; Mfady D; Van Wagoner DR
    Cardiovasc Pathol; 2015; 24(1):19-25. PubMed ID: 25213716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Risk Stratification System for Predicting In-Hospital Mortality Following Coronary Artery Bypass Grafting Surgery with Impaired Left Ventricular Ejection Fraction.
    Lin H; Hou J; Tang H; Chen K; Guo S; Wang L; Sun H; Zheng Z; Hu S
    Heart Surg Forum; 2020 Aug; 23(5):E621-E626. PubMed ID: 32990579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restrictive mitral annuloplasty with or without coronary artery bypass grafting in ischemic mitral regurgitation.
    Kainuma S; Toda K; Miyagawa S; Yoshikawa Y; Hata H; Yoshioka D; Kawamura T; Kawamura A; Ueno T; Kuratani T; Kondoh H; Masai T; Hiraoka A; Sakaguchi T; Yoshitaka H; Shirakawa Y; Takahashi T; Saito S; Monta O; Sado J; Kitamura T; Komukai S; Hirayama A; Taniguchi K; Sawa Y
    ESC Heart Fail; 2020 Aug; 7(4):1560-1570. PubMed ID: 32400096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative value of BNP and NT-proBNP in diagnosis of heart failure.
    Fonseca C; Sarmento PM; Minez A; Gonçalves E; Covas R; Dias AR; Pina MJ; Ceia F
    Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does on-pump/beating-heart coronary artery bypass grafting offer better outcome in end-stage coronary artery disease patients?
    Prifti E; Bonacchi M; Giunti G; Frati G; Proietti P; Leacche M; Salica A; Sani G; Brancaccio G
    J Card Surg; 2000; 15(6):403-10. PubMed ID: 11678463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and trends of heart failure admissions after coronary artery bypass grafting surgery.
    Moreyra AE; Deng Y; Wilson AC; Cosgrove NM; Kostis WJ; Kostis JB;
    Eur J Heart Fail; 2013 Jan; 15(1):46-53. PubMed ID: 23097068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.